全文获取类型
收费全文 | 572篇 |
免费 | 22篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 21篇 |
妇产科学 | 6篇 |
基础医学 | 52篇 |
口腔科学 | 14篇 |
临床医学 | 77篇 |
内科学 | 145篇 |
皮肤病学 | 23篇 |
神经病学 | 30篇 |
特种医学 | 93篇 |
外科学 | 35篇 |
综合类 | 27篇 |
预防医学 | 41篇 |
眼科学 | 10篇 |
药学 | 31篇 |
中国医学 | 2篇 |
肿瘤学 | 21篇 |
出版年
2023年 | 4篇 |
2022年 | 5篇 |
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2017年 | 8篇 |
2016年 | 5篇 |
2015年 | 5篇 |
2014年 | 9篇 |
2013年 | 13篇 |
2012年 | 23篇 |
2011年 | 27篇 |
2010年 | 13篇 |
2009年 | 20篇 |
2008年 | 25篇 |
2007年 | 30篇 |
2006年 | 11篇 |
2005年 | 27篇 |
2004年 | 16篇 |
2003年 | 9篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 26篇 |
1999年 | 20篇 |
1998年 | 22篇 |
1997年 | 18篇 |
1996年 | 28篇 |
1995年 | 17篇 |
1994年 | 11篇 |
1993年 | 26篇 |
1992年 | 6篇 |
1991年 | 8篇 |
1990年 | 6篇 |
1989年 | 11篇 |
1988年 | 18篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 7篇 |
1984年 | 11篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1973年 | 3篇 |
排序方式: 共有629条查询结果,搜索用时 15 毫秒
101.
回春液补肾助阳药效学的实验研究 总被引:2,自引:0,他引:2
回春液由人参、鹿茸、貂鞭等名贵中药组成。有补肾助阳,填精益气等功效。药效学研究证实,该药有促进幼鼠发育及增加去势大鼠前列腺——精液囊的重量,亦显著增加小鼠血红蛋白的含量,表明回春液有雄性激素样作用。 相似文献
102.
Background and purpose:
Angiotensin II receptor antagonists (ARBs), originally developed for antihypertensive properties, have pleiotropic effects including direct vascular actions. We tested the hypothesis that the ARB irbesartan would be effective against micro- and macrovascular complications of the prediabetic metabolic syndrome using the obese, insulin-resistant JCR : LA-cp rat that exhibits micro- and macrovascular disease with ischaemic myocardial lesions and renal disease.Experimental approach:
Obese male rats were treated with irbesartan (30 mg·kg−1·day−1, incorporated into chow) from 12 to 25 weeks of age.Key results:
Irbesartan treatment caused no change in food intake or body weight. Fasting glycaemic control of the JCR : LA-cp rats was marginally improved, at the expense of increased plasma insulin levels (∼50%). Fasting plasma triglycerides were marginally reduced (∼25%), while cholesterol concentrations were unchanged. Elevated concentrations of adiponectin, monocyte chemotactic protein-1 and plasminogen activator inhibitor-1 were reduced along with severity of glomerular sclerosis. Macrovascular dysfunction (aortic hypercontractile response to noradrenergic stimulus and reduced endothelium-dependent relaxation) was improved and frequency of ischaemic myocardial lesions reduced (62%).Conclusions and implications:
Irbesartan reduces markers of inflammation and prothombotic status, improves macrovascular function and reduces glomerular sclerosis and myocardial lesions in a model of the metabolic syndrome. Unlike pharmaceutical agents targeted on metabolic dysfunction, irbesartan reduced end-stage disease without major reduction of plasma lipids or insulin. The protective effects appear to be secondary to unknown intracellular mechanisms, probably involving signal transduction pathways. Understanding these would offer novel pharmaceutical approaches to protection against cardiovascular disease. 相似文献103.
Transfusion-related acute lung injury caused by an NB2 granulocyte- specific antibody in a patient with thrombotic thrombocytopenic purpura 总被引:3,自引:0,他引:3
HLA and granulocyte-specific antibodies have been implicated in the production of transfusion-related acute lung injury (TRALI). Reported here is a case that suggests that the patient's preexisting condition may play an important role in determining whether TRALI develops upon transfusion of blood products containing anti-white cell (WBC) antibodies. A 29-year-old woman with thrombotic thrombocytopenic purpura (TTP) underwent an uneventful 1.5-volume plasma exchange, which was followed by the transfusion of 2 red cell (RBC) units. At the end of the second RBC transfusion, the patient developed clinical signs and symptoms of noncardiogenic pulmonary edema. Serologic studies demonstrated that the serum from the second RBC donor had no HLA antibodies but did have a granulocyte-specific antibody (anti-NB2) that caused the agglutination of the recipient's granulocytes, which were NB2 positive. Serum from the donor of the first RBC unit and serum from the donors of units used in the exchange had no HLA or granulocyte-specific antibodies that reacted with the recipient's WBCs. Because the donor implicated in this reaction had a history of 21 blood donations, none of which had been associated with a transfusion reaction, we suggest that the patient's preexisting condition played a significant role in this episode of TRALI, owing to the granulocyte-specific antibody. 相似文献
104.
Jonathan E. Brammer Dai Chihara L. Michelle Poon Paolo Caimi Marcos de Lima Celina Ledesma Gabriela Rondon Stefan O. Ciurea Yago Nieto Michelle Fanale Bouthaina Dabaja Richard T. Maziarz Richard E. Champlin Chitra Hosing Yasuhiro Oki 《Clinical Lymphoma, Myeloma & Leukemia》2018,18(1):e41-e50
Background
Extra-Nodal natural killer/T-cell lymphoma (ENKL) is a rare lymphoma representing approximately 5-10% of T-cell non-Hodgkin lymphomas diagnosed in the United States each year. Patients with advanced stage III/IV ENKL and relapsed refractory ENKL have a poor prognosis even despite aggressive therapy and stem cell transplantation (SCT). We conducted a review of the management of 37 patients with advanced-stage and relapsed/refractory ENKL in a predominantly non-Asian cohort evaluating both chemotherapy and SCT outcomes.Patients and Methods
We evaluated clinical outcomes in all patients treated for advanced stage III/IV or relapsed/refractory ENKL at MD Anderson cancer center between 2000-2014. Next, we collected stem cell transplant data from four transplant institutions to further evaluate outcomes of both allogeneic (allo-SCT) and autologous (auto-SCT) stem cell transplantation in ENKL.Results
OS and PFS were 73% and 45% at one year, and 30% and 19% at 3-years, respectively. SMILE chemotherapy was more effective in maintaining a CR compared to CHOP (83% vs 17%). Only achievement of CR was prognostic for OS (HR 0.245, p=0.002) and PFS (HR 0.072, p)Conclusion
Our results suggest that achievement of a CR is imperative in patients with advanced ENKL, and is desirable for any patient for whom auto-SCT is utilized. SMILE-based chemotherapy appeared effective in attaining a CR, and was also an effective salvage regimen. For patients attaining a first CR, auto-SCT should be strongly considered, but should definitely be utilized in patients attaining CR2. For patients with refractory disease, allo-SCT can be considered in a selected group of patients. 相似文献105.
Michele Matarazzo Teresa Arroyo‐Gallego Paloma Montero Vernica Puertas‐Martín Ian Butterworth Carlos S. Mendoza María J. Ledesma‐Carbayo María Jos Cataln Jos Antonio Molina Flix Bermejo‐Pareja Juan Carlos Martínez‐Castrillo Lydia Lpez‐Manzanares Araceli Alonso‐Cnovas Jaime Herreros Rodríguez Ignacio Obeso Pablo Martínez‐Martín Jos Carlos Martínez‐vila Agustín Gmez de la Cmara Martha Gray Jos A. Obeso Luca Giancardo lvaro Snchez‐Ferro 《Movement disorders》2019,34(10):1488-1495
106.
Skin permeation of econazole nitrate formulated in an enhanced hydrophilic multiple emulsion 下载免费PDF全文
Joaquim Suñer‐Carbó Antonio Boix‐Montañés Lyda Halbaut‐Bellowa Nelvis Velázquez‐Carralero Joanna Zamarbide‐Ledesma Nuria Bozal‐de‐Febrer Ana Cristina Calpena‐Campmany 《Mycoses》2017,60(3):166-177
Local delivery of imidazolic antifungals is limited by its extreme lipophilicity. Multiple emulsions (ME) are a potential vehicle to enhance the delivery of econazole nitrate (ECN), an antifungal targeted to deep‐seated epidermal yeast infections. An 1% ECN hydrophilic ME was compared with a commercial formulation in terms of rheology, droplet size and in vitro antifungal activity against Candida species. Comparative in vitro drug release, human skin permeation and drug retention were investigated using vertical diffusion cells. Rheology demonstrated a pseudoplastic shear thinning with thixotropy facilitating skin residence. No significant aggregation or droplet size variations were observed during a 6‐month stability storage. Both formulations exhibited similar release levels achieving asymptotic values in 5 h. ECN skin permeation levels from the multiple emulsion resulted to be significantly higher than those of the commercial formulation, attributable to differences in formulation polarity and excipients composition. Conversely, similar drug accumulation levels in skin were obtained (40‐130 ppm). These concentrations resulted to be comparable with obtained MIC values (2‐78 ppm), confirming the in vitro antimicrobial efficacy of both formulations. A similar skin retention and a higher permeation rate over the existing formulations is considered an improved approach to target the drug to deep epidermis. 相似文献
107.
108.
109.
Ranjani Ramachandran R Lakshmi Kumar D Ravi K Devika Fathima Rahman DF Wares 《亚太热带病杂志(英文版)》2011,1(1):47-49
ObjectiveTo combine isoniazid (INH) and rifampicin (RIF) in a single media to detect and evaluate multi-drug resistant Mycobacterium tuberculosis (MDR-TB) strains using clinical specimens by direct and indirect drug susceptibility testing (DST).MethodsDrug susceptibility testing for INH and RIF using individual and combined drug media was performed by minimum inhibitory concentration (MIC) method on direct clinical specimens.ResultsThe combined drug media showed complete concordance with individual drug media in the detection of MDR-TB by direct DST method and 89% efficiency with indirect DST method. Susceptibility results were available by 3 weeks after the receipt of clinical specimen using direct DST on combined drug media.ConclusionsCombined drug media can be used as a fast track method in large scale studies warranting detection of MDR-TB. 相似文献
110.
Martínez-Vázquez M Estrada-Reyes R Araujo Escalona AG Ledesma Velázquez I Martínez-Mota L Moreno J Heinze G 《Journal of ethnopharmacology》2012,139(1):164-170